Hayano J, Takahashi H, Toriyama T, Mukai S, Okada A, Sakata S, Yamada A, Ohte N, Kawahara H
Third Department of Internal Medicine, Nagoya City University Medical School, Nagoya, Japan.
Nephrol Dial Transplant. 1999 Jun;14(6):1480-8. doi: 10.1093/ndt/14.6.1480.
Mortality is high in chronic haemodialysis patients with cardiovascular disease, and many of them die suddenly. Reduced heart rate variability (HRV) is an increased risk for death in various populations, but its prognostic value in haemodialysis patients remains uninvestigated.
We analysed the associations between 24-h HRV measures and long-term mortality through a prospective follow-up of 31 chronic haemodialysis patients who underwent diagnostic coronary angiography.
Of the 31 patients, at baseline, seven had a previous myocardial infarction, five had a history of congestive heart failure and 14 had significant (> or =75%) coronary stenosis (four had multi-vessel stenosis). During follow-up for 60+/-5 months, 14 patients died, 11 of them suddenly. A left ventricular ejection fraction of <0.45, multi-vessel coronary stenosis, ventricular tachycardia on 24-h ECG and decreased/abnormal 24-h HRV (triangular index <22 and abnormal Poincaré plot) carried a univariate risk of all-cause death, while the risk of sudden death was only correlated with decreased HRV (standard deviation of normal-normal R-R interval <50 ms, triangular index <22 and ultra-low frequency power <8.7 ln(ms2)). Multivariate analysis revealed that a triangular index <22 was the best predictor of increased risk for both all-cause and sudden death (hazards ratio (95% CI); 8.1 (1.3-48.6) and 12.6 (1.3-126.4), respectively) and that the association was independent of cardiac function, macrovascular diseases, ventricular arrhythmias and cardiovascular risk factors. The 5-year mortality when the triangular index was > or =22 or <22 was 33 or 88% for patients with coronary artery disease and 0 or 50% for those without.
These results indicate that HRV has an independent prognostic value in chronic haemodialysis patients and identifies an increased risk for all-cause and sudden death.
患有心血管疾病的慢性血液透析患者死亡率很高,其中许多人猝死。心率变异性(HRV)降低在不同人群中是死亡风险增加的因素,但其在血液透析患者中的预后价值仍未得到研究。
我们通过对31例接受诊断性冠状动脉造影的慢性血液透析患者进行前瞻性随访,分析了24小时HRV测量值与长期死亡率之间的关联。
31例患者中,基线时,7例曾有心肌梗死,5例有充血性心力衰竭病史,14例有显著(≥75%)冠状动脉狭窄(4例有多支血管狭窄)。在60±5个月的随访期间,14例患者死亡,其中11例猝死。左心室射血分数<0.45、多支血管冠状动脉狭窄、24小时心电图出现室性心动过速以及24小时HRV降低/异常(三角指数<22且庞加莱图异常)具有全因死亡的单因素风险,而猝死风险仅与HRV降低相关(正常到正常R-R间期标准差<50毫秒、三角指数<22且超低频功率<8.7 ln(ms2))。多变量分析显示,三角指数<22是全因死亡和猝死风险增加的最佳预测指标(风险比(95%可信区间);分别为8.1(1.3 - 48.6)和12.6(1.3 - 126.4)),且这种关联独立于心脏功能、大血管疾病、室性心律失常和心血管危险因素。对于冠状动脉疾病患者,三角指数≥22或<22时的5年死亡率分别为33%或88%,对于无冠状动脉疾病患者则为0或50%。
这些结果表明,HRV在慢性血液透析患者中具有独立的预后价值,并可识别全因死亡和猝死风险增加。